Concepedia

Publication | Closed Access

Weekly versus Three-Weekly Cisplatin-based Concurrent Chemoradiotherapy as definitive treatment in Head and Neck Cancer- Where do we stand?

22

Citations

0

References

2016

Year

Sheh Rawat, Himanshu Srivastava, Parveen Ahlawat, Mrinal Pal, Gopila Gupta, Deepika Chauhan, Sarthak Tandon, Rishabh Khurana
PubMed

Abstract

Weekly cisplatin 35 mg/m2 chemotherapy concurrent with radiotherapy is equally effective and less toxic in terms of neutropenia, hypomagnesemia and need for supportive measures than the conventional 3 weekly cisplatin 100 mg/m2 regimen.